Results 171 to 180 of about 26,593 (244)

Mathematical Model for Evaluation of Tumor Response in Targeted Radionuclide Therapy with ²¹¹At Using Implanted Mouse Tumor. [PDF]

Int J Mol Sci, 2022
Yonekura Y, Toki H, Watabe T, Kaneda-Nakashima K, Shirakami Y, Ooe K, Toyoshima A, Nakajima H, Tomiyama N, Bando M.   +9 more
europepmc   +1 more source

Targeted radionuclide therapy and diagnostic imaging of SSTR positive neuroendocrine tumors: a clinical update in the new decade. [PDF]

Front Nucl Med
Haugh KN, Sanwick AM, Chaple IF.
europepmc   +1 more source

Fibroblast activation protein-targeted radionuclide therapy: background, opportunities, and challenges of first (pre)clinical studies. [PDF]

Eur J Nucl Med Mol Imaging, 2023
Privé BM, Boussihmad MA, Timmermans B, van Gemert WA, Peters SMB, Derks YHW, van Lith SAM, Mehra N, Nagarajah J, Heskamp S, Westdorp H.   +10 more
europepmc   +1 more source

Targeted radionuclide therapy for gliomas: Emerging clinical trial landscape. [PDF]

Neuro Oncol
Weller M, Albert NL, Galldiks N, Bink A, Preusser M, Sulman EP, Treyer V, Wen PY, Tonn JC, Le Rhun E.   +9 more
europepmc   +1 more source

A Review on Tumor Control Probability (TCP) and Preclinical Dosimetry in Targeted Radionuclide Therapy (TRT). [PDF]

Pharmaceutics, 2022
Spoormans K, Crabbé M, Struelens L, De Saint-Hubert M, Koole M.   +4 more
europepmc   +1 more source

Targeted radionuclide therapy for patients with central nervous system metastasis: Overlooked potential? [PDF]

Neuro Oncol
Le Rhun E, Albert NL, Hüllner M, Franceschi E, Galldiks N, Karschnia P, Minniti G, Weiss T, Preusser M, Ellingson BM, Weller M.   +10 more
europepmc   +1 more source

Evaluation of ¹⁷⁷Lu-Labeled Lipiodol as a Targeted Radionuclide Therapy for Hepatocellular Carcinoma in a Preclinical Xenograft Model. [PDF]

Mol Imaging Biol
Kono Y, Utsunomiya K, Shiraishi T, Kan N, Shiojima I, Maruyama K, Tanigawa N.   +6 more
europepmc   +1 more source

Investigating the significance of SPECT/CT-SUV for monitoring ¹⁷⁷Lu-PSMA-targeted radionuclide therapy: a systematic review. [PDF]

BMC Med Imaging
Alkahtani TO.
europepmc   +1 more source

Efficacy of combined targeted radionuclide therapy and immune checkpoint Inhibition in animal tumour models: a systematic review and meta-analysis of the literature. [PDF]

Eur J Nucl Med Mol Imaging
Kleinendorst SC, Hooijmans CR, Muselaers S, Oosterwijk E, Konijnenberg M, Heskamp S, van Lith SAM.   +6 more
europepmc   +1 more source

Radiopharmaceutical dosimetry in targeted radionuclide therapy

, 2019
La médecine nucléaire est une spécialité médicale dont l'une des applications est l'étude de la physiologie des organes et du métabolisme de divers types de tumeurs. Les produits pharmaceutiques liés à un isotope radioactif (médicament radio-pharmaceutique, MRP) sont étudiés en préclinique avant d'être utilisés chez l'homme.
openaire   +1 more source